CVE-2022-45285
Vsourz Digital Advanced Contact form 7 DB Versions 1.7.2 and 1.9.1 is vulnerable to Cross Site...
Vsourz Digital Advanced Contact form 7 DB Versions 1.7.2 and 1.9.1 is vulnerable to Cross Site Scripting (XSS).
Attack profile
How easy it is to exploit
- Attack vector
- Network
- Complexity
- Low
- Privileges needed
- None
- User interaction
- Required
What an attacker can affect
- Confidentiality
- Low
- Integrity
- Low
- Availability
- None
Exploit likelihood
What each source reports
NVD Score used
Vsourz Digital Advanced Contact form 7 DB Versions 1.7.2 and 1.9.1 is vulnerable to Cross Site Scripting (XSS).
- Record
CVE-2022-45285- CVSS 3.1
- 6.1 Medium
CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:C/C:L/I:L/A:N - Weakness
- CWE-79
- Updated
- 2026-11-02
CVE List
Vsourz Digital Advanced Contact form 7 DB Versions 1.7.2 and 1.9.1 is vulnerable to Cross Site Scripting (XSS).
- Record
CVE-2022-45285- CVSS 3.1
- 6.1 Medium
CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:C/C:L/I:L/A:N - Weakness
- CWE-79
- Updated
- 2026-11-02
EUVDEUVD-2022-48185
Vsourz Digital Advanced Contact form 7 DB Versions 1.7.2 and 1.9.1 is vulnerable to Cross Site Scripting (XSS).
- Record
EUVD-2022-48185- CVSS 3.1
- 6.1 Medium
CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:C/C:L/I:L/A:N - Updated
- 2026-11-02
GitHub AdvisoriesGHSA-249j-wgjq-35gx
Vsourz Digital Advanced Contact form 7 DB Versions 1.7.2 and 1.9.1 is vulnerable to Cross Site...
Vsourz Digital Advanced Contact form 7 DB Versions 1.7.2 and 1.9.1 is vulnerable to Cross Site Scripting (XSS).
- Record
GHSA-249j-wgjq-35gx- CVSS 3.1
- 6.1 Medium
CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:C/C:L/I:L/A:N - Weakness
- CWE-79
- Updated
- 2026-11-02
Affected products
History
| Recorded | Changed | Sources |
|---|---|---|
| first indexed | CVE List, EUVD, GitHub Advisories, NVD |
Dates are when Every CVE recorded each change. Upstream dates may differ.
In short
CVE-2022-45285 is a medium vulnerability (CVSS 6.1) in Vsourz Advanced Cf7 Db, published February 13, 2023. No source lists public exploit code. EPSS puts the chance of exploitation in the next 30 days at 0.50%, the 42nd percentile. No source names a fixed version.